Latest News
-
UCAS Holds 2025 Graduation and Degree Awarding Ceremony
On July 6, University of Chinese Academy of Sciences (UCAS) holds the 2025 Graduation and Degree Awarding Ceremony at Yanqi Lake Campus. Over 180 supervisors and teachers attended the ceremony to turn the tassels for UCAS graduates. Over 6,000 graduates attended the ceremony, with 10,000 other attendants witnessing their graduation, including graduates’ families and friends.
In 2025, 7,114 UCAS students received doctoral degrees, 8,108 students received master's degrees, and 394 students received bachelor's degrees. ZHOU Qi, the President of UCAS, delivered a speech entitled “Be a Trustworthy Person” on the ceremony. WANG Chi, a member of CAS, Ph.D. supervisor of UCAS, and a research fellow of the National Space Science Center of the Chinese Academy of Sciences, spoke as the representative of UCAS supervisors. ZHANG Hanle, CHAI Jiajun and Alexandra Elena Carst spoke as representatives of undergraduate, graduate and international students of the Class of 2025, respectively.
Editor: GAO Yuan
-
2025-07-09 16:56:01
UCAS-ANSO-APRU International Summer School: “Earth Science for a Shared Future” Opens
-
2025-07-08 10:35:20
UCAS holds 2025 international College global alumni network hub development forum
-
2025-05-22 10:20:39
China Focus: China, Denmark to deepen cooperation on green innovation
more
Research News
-
Chinese scientists unveil new anti-tumor immune mechanism
BEIJING, June 25 (Xinhua) -- Chinese researchers have uncovered a previously unreported immune-activating function of methotrexate, a classic immunosuppressive drug, providing a theoretical foundation for its combined use with tumor immunotherapy and radiotherapy in clinical practice.
The findings have been published online in Science Translational Medicine.
While significant progress has been made in tumor immunotherapy in recent years, challenges of primary and acquired drug resistance persist.
In this study, the research team revealed methotrexate's previously unrecognized immune-activating role within the tumor microenvironment, said Zheng Mingyue, corresponding author of the paper and researcher at Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences.
The team developed a novel algorithm predicting that methotrexate exerts its anti-tumor immune effect by inhibiting ENPP1, an enzyme widely distributed across various human tissues and cells.
The research demonstrated that low-dose methotrexate treatment not only significantly enhanced the anti-tumor efficacy of immunotherapy and radiotherapy in mouse models but also played a similar synergistic role in preliminary clinical trials.
According to the results, methotrexate treatment can enhance the efficacy of radiotherapy and help overcome the drug resistance of tumors to immune checkpoint blockade therapy.
This discovery provides a theoretical basis for combining methotrexate with radiotherapy or immunotherapy, Zheng said, adding that it also paves the way for novel anti-tumor drug development strategies and holds significant clinical translation value.
Source: Xinhua
Editor: GAO Yuan
-
Breakthrough: CP Violation Established in Bayron Decays
-
Researchers reveal key mechanism behind bacterial cancer therapy
-
Chinese scientists find evidence supporting existence of intermediate-mass black holes
more
